Skip to content
★ Sign in to follow
ステラファーマ株式会社 logo

ステラファーマ株式会社 Stock: price and insider trades · Japan

JP·Mcap JP¥14.5BHealth Care

ステラファーマ株式会社: what insiders have been doing

Every trade that managers of ステラファーマ株式会社 disclose to EDINET (Japan FSA) is tracked on this page. The company sits in the Health Care sector. Between 26 October 2025 and 26 October 2026, 2 insiders published 8 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

With 8 filings in twelve months, the company is more active than the median of 3 filings across the 3,205 companies we follow on the same exchange. The full history, which starts in 2022, counts no purchases against 13 sales.

Over the last twelve months, not one insider purchase of ステラファーマ株式会社 stock was filed. The median gap between a trade and its publication by EDINET (Japan FSA) is 7 days. The shorter that gap, the sooner other investors can see what insiders have done.

Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.

Insider Decl.
42
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€10M
13 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 18,869 of 26,911 companies
38.0
score / 100
Value
24
Quality
52
FCF yld-2.8%
Earn yld-6.3%
EV/EBITDA·
ROE-27%
Gross mgn86%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥402
Analyst consensus
·
Income statement
RevenueJP¥323.4M
Gross profitJP¥279.2M86% margin
EBITDA-JP¥742.2M-229% margin
Net income-JP¥780.9M-263.8% margin
Valuation
P/Book4.4x
Beta0.33
Balance sheet & cash
Market capJP¥14.5B
Total debtJP¥747.1M
Free Cash Flow-JP¥346.2M
Debt / Equity28%
Profitability & ownership
ROE-27.2%
ROA-10.1%
% insiders39.2%
% institutions6.0%
Last declaration on 9 September 2026
Declarations42 total

25 of 42 declarations

About ステラファーマ株式会社

Stella Pharma Co., Ltd. is a company specializing in the health and pharmaceutical sector. It is listed on the XTKS market.